TP53 and neoplasm: Based on the high prevalence of p53 mutations in TNBC, the ability of statins to degrade mutant p53, and thereby inhibit tumour cell proliferation, the aim of our study was to test the hypothesis that these drugs might provide a new treatment for patients with TNBC.